SEC Form 4 · accession 0000899243-18-002337
Dicerna Pharmaceuticals Inc · DRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Jan 26, 2018
Accepted (ET)
Jan 30, 2018 · 9:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001399529
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 26, 2018 | M | 360 | $3.42 | A | 71,788 | I | Langer Family Holdings, LLLP |
| Common Stock | holding | — | — | — | 43,595 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2,F3 | $3.42 | Jan 26, 2018 | M | 360 | D | — | Feb 14, 2018 | Common Stock | 360 | 0 | I |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.
- F21/12 vests per month, commencing 1 year after the vesting start date of 11/15/2008.
- F3This option was originally reported in the reporting person's Form 3, filed on January 29, 2014, with an expiration date of June 2, 2019. However, the correct expiration date is February 14, 2018.